EUCTR2014-000173-39-NL进行中（未招募）不适用
The effect of IL-1 inhibition by anakinra in acute gout- A proof of concept study
Jan van Breemen Research Institute Reade and VU University Medical Centre0 个研究点开始时间: 2014年7月3日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with a crystal-confirmed diagnosis of gout
- •Patients with known intolerance or contra-indications for colchicine and NSAIDs
- •Patients with a currently acute gout flare
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Patiënten met de diagnose jicht, die is gesteld door middel van identificatie van kristallen in synoviaal vocht.
- •Patiënten bekend met intolerantie of contra-indicaties voor behandeling met colchicine en NSAIDs
- •Patiënten met een acute jicht aanval
研究者
相似试验
招募中
不适用
The effect of IL-1 inhibition by anakinra in acute gout;- A proof of concept studyGout.10023213NL-OMON40227Jan van Breemen Instituut20
已完成
不适用
Effect of anakinra (soluble interleukin-1 receptor antagonist) as combination therapy: second UK combination therapy in early rheumatoid arthritisMusculoskeletal DiseasesRheumatoid arthritisISRCTN15819795King's College London (UK)158
进行中（未招募）
1 期
Anakinra as prevention of fever and mucositis in patients with a stem cell transplantatioFebrile neutropenia and mucositisMedDRA version: 20.0Level: LLTClassification code 10028127Term: MucositisSystem Organ Class: 100000004867MedDRA version: 20.0Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2018-005046-10-NLRadboud university medical center90
招募中
2 期
Anakinra: safety and efficacy of interleukin-1 pathway inhibitor anakinra for the management of fever during neutropenia and mucositis in patients with multiple myeloma receiving an autologous hematopoietic stem cell transplantation after high-dose melphalan - A randomized controlled trialand fever during neutropenia)mucositis and febrile neutropenia(inflammation of the lining of the digestive system100188651001796910005908NL-OMON48856Radboud Universitair Medisch Centrum90
已完成
不适用
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in obese, insulin resistant individualsmaturity-onset diabetestype 2 diabetes mellitus10018424NL-OMON33714niversitair Medisch Centrum Sint Radboud12